Ketorolac Tromethamine

酮咯酸氨丁三醇

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameKetorolac Tromethamine
Drug Alias NameKetorolac tromethamol酮洛来克酮咯酸三羟甲氨基甲基ketorolacumketorolaco +[20
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Cyclooxygenase-1
Therapy Area/IndicationsPostoperative inflammationBurnsBites and Stings +[39
Global Approved IndicationsPainConjunctivitis, Allergic
Approved Indications in ChinaConjunctivitis, Allergic
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[11
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active IndicationsPostoperative inflammationBurnsBites and Stings +[23
Inactive IndicationsChronic PainBack PainMacular Edema +[16

Other Information

ATC CodeM01AB15S01BC05